Shalley N. Kudalkar - Concepedia

Author

Shalley N. Kudalkar

Yale University ORCID

Also Known As

S.N. Kudalkar, Shalley Kudalkar, Shalley N Kudalkar, Shalley N. Kudalkar, Shalley Nidhish Kudalkar

Publications

597

Citations

H-Index

Concepts

All Affiliations

Yale University Vanderbilt University Auburn University Cornell University Northeastern University

About

Shalley N. Kudalkar is an author at Yale University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	91
2	Biochemistry	2	2	41
3	Chemical Biology	2	2	53
4	Natural Sciences	1	1	30
5	Biomolecular Engineering	1	1	23

Shalley N. Kudalkar

Publications

560

Citations

H-Index

Page 1

	Year	Citations
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations Chunhui Zhang, Elizabeth A. Stone, M.G. Deshmukh, ACS Central Science	2021	253
Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography Albert H. Chan, Won‐Gil Lee, Krasimir A. Spasov, Proceedings of the National Academy of Sciences	2017	49
Action at a Distance Anna L. Blobaum, Shu Xu, Scott W. Rowlinson, Journal of Biological Chemistry	2015	46
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection Shalley N. Kudalkar, Jagadish Beloor, Elias Quijano, Proceedings of the National Academy of Sciences	2017	36
13-Methylarachidonic Acid Is a Positive Allosteric Modulator of Endocannabinoid Oxygenation by Cyclooxygenase Shalley N. Kudalkar, Spyros P. Nikas, Philip J. Kingsley, Journal of Biological Chemistry Crystal StructureChemical BiologyCannabinoid PharmacologyRedox BiologyOxidative Stress	2015	30
Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV Shalley N. Kudalkar, Irfan Ullah, Nicole Bertoletti, Antiviral Research MedicineHuman RetrovirusAntiviral Drug DevelopmentAntiviral TherapyMolecular Biology	2019	27
(<i>R</i>)-<i>N</i>-(1-Methyl-2-hydroxyethyl)-13-(<i>S</i>)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes Yingpeng Liu, Lipin Ji, Marsha R. Eno, Journal of Medicinal Chemistry	2018	25
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic Valerie W. Shurtleff, M. E. Layton, Craig A. Parish, Journal of Medicinal Chemistry ImmunologyAntiviral DrugViral Structural ProteinChemical BiologyAntiviral Drug Development	2024	23
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Molecular Pharmacology	2017	19
Structure-Guided Identification of DNMT3B Inhibitors Ana S. Newton, John C. Faver, Goran Micevic, ACS Medicinal Chemistry Letters	2020	19

Page 1